BRAF and melanoma: Studies have demonstrated that in the metastatic melanoma cells the expression of tyrosinase is increased and down-regulation of the Tyr gene can affect inhibition of cell proliferation, promote apoptosis, and reduce hyperpigmentation by affecting signaling pathways such as the RAS/BRAF/MAPK (35-37).